Kisqali 600 MG daily dose UU 63S
Ended Awarded Last action
- Contract number
- SPE2DR26F7UZ0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,280
Award facts
- Contract value 100% obligated
- $12,280.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,280 delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Kisqali 600 mg daily dose tablets (63-count units). This firm fixed-price, competitively awarded contract has an ultimate completion date of January 29, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed on a full and open basis. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor that serves critical federal healthcare procurement needs.
This delivery order is issued under Cencora's comprehensive Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which functions as a global pharmaceutical support vehicle for military healthcare programs. Kisqali (ribociclib), a specialty oncology medication, represents the type of brand-name pharmaceutical products typically supplied through this IDC to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery order structure and firm fixed pricing demonstrate the flexibility of the underlying indefinite delivery vehicle in meeting specific pharmaceutical supply requirements across the military health system.
Quick answers
Who was awarded contract SPE2DR26F7UZ0?
SPE2DR26F7UZ0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F7UZ0 worth?
The government has obligated $12,280 on SPE2DR26F7UZ0.
Is contract SPE2DR26F7UZ0 an order under another contract?
Yes. SPE2DR26F7UZ0 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7UZ0 competed?
The extent of competition for SPE2DR26F7UZ0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award